These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27804107)

  • 21. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-Based Dose Optimization in Children.
    Ramsey LB; Brown JT; Vear SI; Bishop JR; Van Driest SL
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():311-331. PubMed ID: 31283429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unleashing the power of preemptive pharmacogenomics.
    O'Donnell PH
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):695-7. PubMed ID: 25658895
    [No Abstract]   [Full Text] [Related]  

  • 25. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
    Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
    Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
    Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
    Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety.
    Beitelshees AL; McLeod HL
    Trends Pharmacol Sci; 2006 Sep; 27(9):498-502. PubMed ID: 16876261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genomic "roadmap" to "better" drugs.
    Liao G; Zhang X; Clark DJ; Peltz G
    Drug Metab Rev; 2008; 40(2):225-39. PubMed ID: 18464044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics in dermatology: tools for understanding gene-drug associations.
    Daneshjou R; Huddart R; Klein TE; Altman RB
    Semin Cutan Med Surg; 2019 Mar; 38(1):E19-E24. PubMed ID: 31051019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
    La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging era of pharmacogenomics: current successes, future potential, and challenges.
    Lee JW; Aminkeng F; Bhavsar AP; Shaw K; Carleton BC; Hayden MR; Ross CJ
    Clin Genet; 2014 Jul; 86(1):21-8. PubMed ID: 24684508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics, pharmacogenomics and ecogenetics.
    Motulsky AG; Qi M
    J Zhejiang Univ Sci B; 2006 Feb; 7(2):169-70. PubMed ID: 16421980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
    Soh TI; Yong WP
    Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
    Relling MV; Klein TE
    Clin Pharmacol Ther; 2011 Mar; 89(3):464-7. PubMed ID: 21270786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics and personalized medicine: mapping of future value creation.
    Hu SX; Foster T; Kieffaber A
    Biotechniques; 2005 Oct; 39(10 Suppl):S1-6. PubMed ID: 18957035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.